Subscribe free to our newsletters via your
. Solar Energy News .




EPIDEMICS
New approaches for Ebola virus therapeutics
by Staff Writers
Liverpool, UK (SPX) Sep 09, 2014


File image.

Researchers from the University of Liverpool, in collaboration with Public Health England, have investigated new ways to identify drugs that could be used to treat Ebola virus infection.

They looked at what proteins inside a cell are critical for the functions of Ebola virus and are hijacked by the virus to help with infection.

One of the proteins they have targeted is known as VP24. This protein disrupts signalling in infected human cells and disrupts the body's immune system and the fight against the virus.

Once the team identified these cellular proteins they were able to find out whether any drugs were already in existence that could block the function of the particular protein.

One such drug identified was ouabain, which can be used in the treatment of heart disease. Administering this drug reduced virus replication in treated cells.

Anti-viral therapy
The study was led by Professor Julian Hiscox from the University's Institute of Infection and Global Health and Professor Roger Hewson at Public Health England.

Professor Hiscox said: "This study shows how existing therapeutics can be identified and potentially repurposed for anti-viral therapy. The technique of using existing and tested drugs for a different purpose can save considerable time and ultimately, lives."

Disrupting cellular proteins important for viruses also has the potential to tackle the problem of resistance to medication. Since the cellular proteins are effectively evolutionarily static, the virus won't be able to adapt to defeat it - as is increasingly the case with treatment by anti-virals used against viral proteins such as seen with influenza virus and HIV infection.

Specialist facilities
The study, which also involved Dr. David Matthews from the University of Bristol, used the unique specialist facilities at PHE Porton, which are designed to safely work with viruses such as Ebola under conditions of high containment.

Co-author Professor Miles Carroll, Head of Research at PHE Porton, said: "This research highlights the anti-viral effects of an already available and licensed human drug which might prove beneficial in a therapeutic setting."

Professor Hiscox concluded: "The philosophy of transiently targeting the function of host cell proteins that are critical for virus infection holds great promise not only for increasing the potential arsenal of drugs against Ebola but other viruses as well."

The paper 'Elucidation of the Ebola virus VP24 cellular interactome and disruption of virus biology through targeted inhibition of host cell protein function', was a collaboration between the University of Liverpool, Public Health England, the University of Bristol and the Health Protection Research Unit in Emerging and Zoonotic Infections. It is published in the Journal of Proteome Research.

The full paper is available here.

.


Related Links
University of Liverpool
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola






Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle








EPIDEMICS
US to send field hospital to Ebola-hit Liberia
Washington (AFP) Sept 08, 2014
The US military will send a field hospital to Liberia for medical staff fighting the Ebola virus, the Pentagon said Monday, as part of an expanded effort to stem the epidemic. The move comes after President Barack Obama promised the American military would offer logistical support to aid countries facing the Ebola outbreak, and amid warnings the number of Ebola cases in Liberia would rise dr ... read more


EPIDEMICS
Ethanol fireplaces: the underestimated risk

ACCESS II Confirms Jet Biofuel Burns Cleaner

Scientists create renewable fossil fuel alternative using bacteria

Scientists produce fuel from gut bacteria, sugar: study

EPIDEMICS
Magal introducing RoboGuard security system in Israel

'Robo Brain' will teach robots everything from the Internet

Robonaut Gets New Legs as Trio Prepares for Homecoming

Russia's First Exoskeleton to Help Physically Impaired

EPIDEMICS
Cutting fossil subsidies must to advance renewables: agency

Stealth wind turbines to become operational in France in 2015

EU calls for study of 2020 renewable energy targets

Go green and prosper, British government says

EPIDEMICS
Director sees road movie a fit for car culture-gripped China

Tesla chief says self-driving cars just around corner

Ride-sharing could cut cabs' road time by 30 percent

Sweden court accepts receivership for Saab carmaker

EPIDEMICS
Clean coal key to combating climate change: Rio Tinto

Tesla picks Nevada for $5 bln battery plant

Changing temperature powers sensors in hard-to-reach places

Ultrasensitive Biosensor from Molybdenite Semiconductor Outshines Graphene

EPIDEMICS
Japan's first female industry chief visits Fukushima plant

Japan places political star at heart of nuclear revival

Australia, India sign long-awaited civil nuclear deal

DSIT Solutions of Israel helps with nuclear power plant security

EPIDEMICS
IRENA: Outdated thinking curbing green energy momentum

Zimbabwe launches $500-mln power units to ease energy woes

Existing power plants will spew 300 billion more tons of carbon dioxide during use

Yale Journal Explores Advances In Sustainable Manufacturing

EPIDEMICS
Brazil cracks 'biggest' Amazon deforestation gang

Brazil arrests 8 in Amazon deforestation swoop

World's primary forests on the brink

New analysis links tree height to climate




The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement All images and articles appearing on Space Media Network have been edited or digitally altered in some way. Any requests to remove copyright material will be acted upon in a timely and appropriate manner. Any attempt to extort money from Space Media Network will be ignored and reported to Australian Law Enforcement Agencies as a potential case of financial fraud involving the use of a telephonic carriage device or postal service.